Search research articles
Contact Us
Filters
Showing results (91-100 of 208) with videos related to
Page
of 21
Sort By:
The Lancet. Oncology
|
March 30, 2012
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin, Marc S Ernstoff, Omid Hamid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
Patrick A Ott, Yung-Jue Bang, Dominique Berton-Rigaud, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2020
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019
Paolo A Ascierto, Carlo Bifulco, Jerome Galon, et al.
The Lancet. Oncology
|
February 15, 2018
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Michael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2012
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors
Lee S Rosen, Igor Puzanov, Gregory Friberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2017
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
Vivek Narayan, Stephen Keefe, Naomi Haas, et al.
Journal of Translational Medicine
|
April 18, 2023
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022
Paolo A Ascierto, Christian Blank, Alexander M Eggermont, et al.
The Lancet. Oncology
|
July 20, 2014
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study
Antoni Ribas, Rene Gonzalez, Anna Pavlick, et al.
Journal of Translational Medicine
|
May 10, 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021
Paolo A Ascierto, Allison Betof Warner, Christian Blank, et al.
Investigational New Drugs
|
October 9, 2014
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors
Igor Puzanov, Jeffrey Sosman, Armando Santoro, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 208) with videos related to
Sort By:
Page
of 21
The Lancet. Oncology
|
March 30, 2012
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin, Marc S Ernstoff, Omid Hamid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
Patrick A Ott, Yung-Jue Bang, Dominique Berton-Rigaud, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2020
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019
Paolo A Ascierto, Carlo Bifulco, Jerome Galon, et al.
The Lancet. Oncology
|
February 15, 2018
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Michael B Atkins, Elizabeth R Plimack, Igor Puzanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2012
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors
Lee S Rosen, Igor Puzanov, Gregory Friberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2017
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
Vivek Narayan, Stephen Keefe, Naomi Haas, et al.
Journal of Translational Medicine
|
April 18, 2023
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022
Paolo A Ascierto, Christian Blank, Alexander M Eggermont, et al.
The Lancet. Oncology
|
July 20, 2014
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study
Antoni Ribas, Rene Gonzalez, Anna Pavlick, et al.
Journal of Translational Medicine
|
May 10, 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021
Paolo A Ascierto, Allison Betof Warner, Christian Blank, et al.
Investigational New Drugs
|
October 9, 2014
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors
Igor Puzanov, Jeffrey Sosman, Armando Santoro, et al.
Page
of 21